Germany Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Treatment Patterns With Brolucizumab in Germany - a Retrospective Cohort Study Based on Longitudinal Prescription Data: REALIZE Study
Condition:   Neovascular Age-related Macular Degeneration Intervention:   Sponsor:   Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
Conditions:   Nasopharyngeal Carcinoma;   Nasopharyngeal Cancer;   Nasopharyngeal Neoplasms;   Nasopharynx Cancer Interventions:   Drug: Nivolumab;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Gemcitabine;   Radiation: Radiotherapy;   Drug: Interferon beta-1a;   Procedure: MRI;   Procedure: PET;   Behavioral: Patient-Reported Outcomes Sponsors:   German Society for Pediatric Oncology and Hematology GPOH gGmbH;   Deutsche Krebshilfe e.V., Bonn (Germany) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials